|
SSH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.770600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.609200E-01 |
| Normal-vs-Stage2 |
7.945600E-01 |
| Normal-vs-Stage3 |
5.201000E-01 |
| Normal-vs-Stage4 |
8.974600E-01 |
| Stage1-vs-Stage2 |
3.204600E-01 |
| Stage1-vs-Stage3 |
8.776200E-01 |
| Stage1-vs-Stage4 |
3.136800E-01 |
| Stage2-vs-Stage3 |
4.326800E-01 |
| Stage2-vs-Stage4 |
8.828800E-01 |
| Stage3-vs-Stage4 |
4.914600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.519600E-01 |
| Normal-vs-AfricanAmerican |
1.963150E-01 |
| Normal-vs-Asian |
1.278620E-01 |
| Caucasian-vs-AfricanAmerican |
4.358400E-01 |
| Caucasian-vs-Asian |
2.626200E-01 |
| AfricanAmerican-vs-Asian |
9.574600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.879600E-01 |
| Normal-vs-Female |
3.429400E-01 |
| Male-vs-Female |
2.733000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.643570E-01 |
| Normal-vs-Age(41-60Yrs) |
4.683200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.417800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.179600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.167400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.379000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.698600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.694300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.449600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.489800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.506200E-01 |
| Classical-VS-Follicular |
1.39209999083789E-09 |
| Classical-VS-Other |
3.067900E-02 |
| Classical-VS-Normal |
2.024200E-02 |
| Tall-VS-Follicular |
1.673790E-02 |
| Tall-VS-Other |
1.196020E-01 |
| Tall-VS-Normal |
8.701800E-01 |
| Follicular-VS-Other |
8.527400E-01 |
| Follicular-VS-Normal |
7.055300E-03 |
| Other-VS-Normal |
1.191780E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.039000E-01 |
| Normal-vs-N1 |
7.698200E-01 |
| N0-vs-N1 |
4.496200E-01 |
|
|
